Stay updated with breaking news from Clinical Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript February 15, 2024 Prothena Corporation plc misses on earnings expectations. Reported EPS is $-1.26 EPS, expectations were $-1.23. PRTA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day ladies and […]
Continued Clinical Progress and Strong Cash Position Highlighted
Strategic Clinical Developments and Financial Overview for the Quarter Ended December 31, 2023
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2024 Earnings Call Transcript February 7, 2024 Viking Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this […]
Key Developments and Financials from 2023 Earnings Report